Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product, By Drug, By Distribution Channel, By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
|発行||AnalystView Market Insights||商品コード||737916|
|出版日||ページ情報||英文 125 Pages
|ペット用アニマルヘルスの世界市場：市場分析・シェア・動向・規模・予測 Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product, By Drug, By Distribution Channel, By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025|
|出版日: 2018年08月03日||ページ情報: 英文 125 Pages||
当レポートでは、世界のペット用アニマルヘルス (動物衛生) の関連市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、動物の種類別・製品別・薬剤別・流通チャネル別・用途別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。
The companion animal health market is estimated to represent a global market of USD 12,506 million by 2017 with growth rate of 4.8%.
Companion animal health industry includes all products and services (i.e. pet services, diagnostics and OTC health) for dogs, horses, cats, and others. The growth of this industry is majorly influenced by the strong increase in the rate of pet ownership. Further, rising strategic collaborations of companies with veterinary organizations to promote awareness and improve animal health augment the market growth significantly. For instance, in 2015, Ceva partnered with the America Association of Feline Practitioners, aimed to encourage pet owner to standardize animal research and surgery practices.
Over the past few years, research and development activities in the veterinary industry have increased and thus the spending on companion animal health. According to American Pet Product Association (APPA), companion animal spending has been consistently on the rise. The organization stated that in 2011, the spending on pet industry was around USD 51 billion and is expected to reach USD 69.36 billion by 2017. The statistics from APPA also stated that around 20.0% of this spending was found to be on over-the-counter products and food & supplies, whereas 25.0% was on veterinary care, including pharmaceuticals.
In May 2015, the Federal Trade Commission (FTC) also stated that the market for veterinary medicine has shown significant growth in recent years. The organization estimated that prescription and over the counter medicine for the dogs and cats are projected to increase with a significant growth rate over the future period. All such facts indicate the rise in adoption of companion animal therapeutics thus, augment the market growth.
Furthermore, the emergence of veterinary information systems and implementation of it into fields such as consultant systems for diagnostic assistance, drug information systems, diagnostic decision assistance, and teaching tools has further aided in the growth of the market. On the flip side, increasing influx of sub-standard therapeutics in veterinary industry is considered to be the major growth restricting factors. Additionally, an absence of streamlining of national regulatory processes will hamper the industry growth to some extent.
Animal type segment is categorized as Equine, Dogs, Sheep & Goats, Cats, and Poultry. Among which, dogs accounted for the largest share of the total market, has recorded USD 4.83 billion in 2016. The demand for dog's therapeutics is relatively greater than other companion animals and the trend is likely to continue over the future period. Thus, companies are increasingly developing novel therapeutics under this segment. For instance, in May 2016, European Medicines Agency (EMA) approved Merck's Bravecto Spot-on solution to treat flea and ticks in dogs. Later, in July 2016, the company also received U.S. FDA approval for this product under name Bravecto Topical.
Product segment is divided into Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others. Increasing research and development activities coupled with favorable government initiatives has helped pharmaceuticals segment to be on the top spot. Drugs segment is categorized into Over the Counter (OTC) and Prescription. Whereas, distribution channel segment is bifurcated into E-commerce, Retail, and Hospitals. The application segment is divided in terms of Clinics, Point-of-Care Facilities, and others.
Regionally, North America accounted for the largest share, closely followed by Europe. Presence of a large number of established pharmaceutical companies that are consistently striving for extensive commercialization of their veterinary products is presumed to be a key factor responsible for growth in both regions. Asia Pacific region is projected to grow with the highest CAGR owing to the rise in adoption of companion animals coupled with the increasing disposable income.
Companies namely Merck, Nutreco, Zoetis, Boehringer Ingelheim, Bayer AG, and Virbac are profiled in detail. Among which, the most notable market participants are Nutreco, Bayer, and Zoetis, accounting for the majority of the revenue share. Key players operating in this market are majorly involved in the development of new products and strategic expansion of their geographic reach. For example, Zoetis offers products such as Cerenia, Convenia, Synulox, Dexdomitor, Cerenia, Palladia, and Rimadyl under companion animal therapeutics. Recently, in December 2016, US FDA approved company's first monoclonal antibody product named "CYTOPOINT". This drug act by neutralizing interleukin-31 (IL-31) and provide long-lasting relief from atopic dermatitis in dogs.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2014 & 2016
Base Year - 2017
Estimated Year - 2018
Projected Year - 2025
Traders, Distributors, and Suppliers
Government and Regional Agencies and Research Organizations
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY ANIMAL TYPE
Sheep & Goats
MARKET, BY PRODUCT
MARKET, BY DRUG
MARKET, BY DISTRIBUTION CHANNEL
MARKET, BY APPLICATION
MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of the World
Middle East and Africa
Client can request additional company profiling as per specific requirements